FCM
LLY icon

Fourpath Capital Management’s Eli Lilly LLY Stock Holding History

Fourpath Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Sell
13,568
-55
-0.4% -$56.2K 2.14% 9
2026
Q1 		$12.5M Sell
13,623
-1,590
-10% -$1.61M 1.8% 11
2025
Q4 		$16.3M Sell
15,213
-21
-0.1% -$20.1K 2.24% 9
2025
Q3 		$11.6M Sell
15,234
-184
-1% -$137K 1.65% 19
2025
Q2 		$12M Sell
15,418
-288
-2% -$224K 1.89% 11
2025
Q1 		$13M Sell
15,706
-199
-1% -$166K 2.26% 8
2024
Q4 		$12.3M Sell
15,905
-2,479
-13% -$2.05M 2.27% 9
2024
Q3 		$16.3M Buy
18,384
+18,049
+5,388% +$16.2M 3% 4
2024
Q2 		$303K Buy
335
+1
+0.3% +$800 0.22% 91
2024
Q1 		$260K Buy
+334
New +$238K 0.18% 108

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fourpath Capital Management's LLY Position: Q2 2026 in Review

Fourpath Capital Management reduced its Eli Lilly (LLY) stake by 0.4% in Q2 2026, selling an estimated $56.2K and leaving 13,568 shares worth $16.3M. The position accounts for 2.14% of the portfolio, ranked #9.

Fourpath Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.3M in Q4 2025. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fourpath Capital Management held 13,568 shares of Eli Lilly worth $16.3M as of Q2 2026.
  • Fourpath Capital Management sold 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
  • Eli Lilly made up 2.14% of Fourpath Capital Management's portfolio in Q2 2026, its #9 holding.
  • Fourpath Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Fourpath Capital Management's Eli Lilly position peaked at $16.3M in Q4 2025.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.